spot_img
Tuesday, August 16, 2022
More
    HomeHealthSTAT+: A CVS whistleblower lawsuit comes at a pivotal moment for the...

    STAT+: A CVS whistleblower lawsuit comes at a pivotal moment for the FTC’s probe of pharma and PBMs

    -



    Three years in the past, a former CVS Well being government informed a U.S. Senate committee listening to that the corporate — which has deep tentacles into the Byzantine system for making pharmaceuticals obtainable — ensures that its prospects obtain the lowest-cost medicines.

    “When these decrease record costs outcome within the lowest web value for the affected person in addition to for the plan, then completely, that’s the popular drug on formulary,” stated Derica Rice, who was an government vp on the time. He was responding to questions concerning the methods through which CVS locations medicines on its formularies, or record of medicines coated by medical health insurance, created by its pharmacy advantages unit.

    Continue to STAT+ to read the full story…



    Source link

    Related articles

    Stay Connected

    0FansLike
    0FollowersFollow
    3,437FollowersFollow
    0SubscribersSubscribe
    spot_img

    Latest posts